The Middle-East & Africa Tumor Ablation Market was worth $0.06 million in 2018 and estimated to be growing at a CAGR of 11.66%, to reach $0.4 million by 2023 Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure which is used to destroy cancer cells in the chest, lung and liver.
Rising Prevalence of cancer is proportional to the growth of tumor ablation market. According to the recent statistics published by the WHO, cancer accounts for 13% of the deaths worldwide. Cancer incidence is expected to increase by 70% over the next couple of decades.
Middle-East & Africa tumor ablation market is driven by factors such as growing aging population and increasing number of people affected with cancer. Increasing demand for minimally invasive cancer treatment procedures and growing awareness about the benefits offered by ablation procedures over the conventional surgical procedures are also some of the key factors adding up to growth of the market. However key challenges related to ablation procedures and strict regulatory guidelines are hindering the growth of the market.
Middle-East & Africa tumor ablation market is segmented by technology, treatment and application. Based on technology the market is sub-segmented as Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices are the dominating technology segment accounting for a share of approximately 35% attributed to its vital role in solid tumour removal in the body. On the basis of treatment the market is segmented as Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Surgical Procedures segment accounted for a prominent share of around 37% owing to increasing prevalence of liver and breast cancers. By application Middle-East & Africa tumor ablation market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer.
Based on geography Middle-East & Africa Tumor Ablation market is segmented into Middle-East and Africa. Middle-East accounted for the largest share of the market with a percentage share of XX% due to high disposable income and wide spread awareness about various ablation procedures where as Africa is estimated to be the fastest growing region with a CAGR of XX% due to high prevalence of the disease in the region.
Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Galil Medical Inc., Angiodynamics, Mermaid Medical, HealthTronics, EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Technology
5.1.1 Radiofrequency Ablation Devices
5.1.2 Microwave Ablation Devices
5.1.3 Cryoablation Devices
5.1.4 Other Ablation Devices
5.2 By Treatment
5.2.1 Surgical Ablation
5.2.2 Laparoscopic Ablation
5.2.3 Percutaneous Ablation
5.3 By Application
5.3.1 Liver Cancer
5.3.2 Breast Cancer
5.3.3 Lung Cancer
5.3.4 Prostrate Metastasis
5.3.5 Other Cancers
6. Geographical Analysis
6.1 Introduction
6.2 Middle-East
6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic Plc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Angiodynamics
8.3 Mermaid Medical
8.4 HealthTronics
8.5 Galil Medical Inc.
8.6 EDAP TMS S.A.
8.7 Boston Scientific Corporation
8.8 SonaCare Medical
8.9 Misonix, Inc.
8.10 Neuwave Medical, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
